Overview

Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function

Status:
Terminated
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The hypothesis of the current proposal is that chronic pioglitazone therapy will result in improved endothelial function, decreased inflammation, and preservation of renal function in patients with CKD but without diabetes.
Phase:
N/A
Details
Lead Sponsor:
Mayo Clinic
Treatments:
2,4-thiazolidinedione
Nitroglycerin
Pioglitazone